# FDA Inspection 1170714 - Hikma Cali Inc. DBA Leucadia Pharmaceuticals - April 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/hikma-cali-inc-dba-leucadia-pharmaceuticals/4fd39120-0db2-40ff-97c3-f8d062d69718
Source feed: FDA_Inspections

> FDA Inspection 1170714 for Hikma Cali Inc. DBA Leucadia Pharmaceuticals on April 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170714
- Company Name: Hikma Cali Inc. DBA Leucadia Pharmaceuticals
- Inspection Date: 2022-04-27
- Classification: No Action Indicated (NAI)
- Project Area: Compliance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1170714 - 2022-04-27](https://www.keypedia.com/records/fda_inspections/hikma-cali-inc-dba-leucadia-pharmaceuticals/339f7ba9-abb2-4f23-a96e-9f5ccca23b75)

Company: https://www.keypedia.com/companies/hikma-cali-inc-dba-leucadia-pharmaceuticals/d24cab77-36de-4f08-b076-0fe315a906ed

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7